Previous Article | Next Article 
Journal of Bacteriology, October 1998, p. 5334-5343, Vol. 180, No. 20
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of Candida albicans ALS2 and
ALS4 and Localization of Als Proteins to the Fungal
Cell Surface
L. L.
Hoyer,*
T. L.
Payne, and
J.
E.
Hecht
Department of Veterinary Pathobiology,
University of Illinois, Urbana, Illinois
Received 26 June 1998/Accepted 18 August 1998
 |
ABSTRACT |
Additional genes in the growing ALS family of
Candida albicans were isolated by PCR screening of a
genomic fosmid library with primers designed from the consensus
tandem-repeat sequence of ALS1. This procedure yielded
fosmids encoding ALS2 and ALS4. ALS2 and
ALS4 conformed to the three-domain structure of
ALS genes, which consists of a central domain of tandemly
repeated copies of a 108-bp motif, an upstream domain of highly
conserved sequences, and a domain of divergent sequences 3' of the
tandem repeats. Alignment of five predicted Als protein sequences
indicated conservation of N- and C-terminal hydrophobic regions which
have the hallmarks of secretory signal sequences and
glycosylphosphatidylinositol addition sites, respectively. Heterologous
expression of an N-terminal fragment of Als1p in Saccharomyces
cerevisiae demonstrated function of the putative signal sequence
with cleavage following Ala17. This signal sequence cleavage site was
conserved in the four other Als proteins analyzed, suggesting identical
processing of each protein. Primary-structure features of the five Als
proteins suggested a cell-surface localization, which was confirmed by
indirect immunofluorescence with an anti-Als antiserum. Staining was
observed on mother yeasts and germ tubes, although the intensity of
staining on the mother yeast decreased with elongation of the germ
tube. Similar to other ALS genes, ALS2 and
ALS4 were differentially regulated. ALS4
expression was correlated with the growth phase of the culture;
ALS2 expression was not observed under many different in
vitro growth conditions. The data presented here demonstrate that
ALS genes encode cell-surface proteins and support the
conclusion that the size and number of Als proteins on the
C. albicans cell surface vary with strain and growth
conditions.
 |
INTRODUCTION |
The opportunistic pathogen
Candida albicans is a fungus that exists in a diverse range
of associations with its human or animal host. C. albicans can survive in the host without overt disease symptoms
and, under the appropriate circumstances, can cause disease that varies
in site and severity. C. albicans infection can be localized and superficial or systemic and disseminated to a wide range
of organs (reviewed in reference 43). This
complexity of interactions of C. albicans with its host
suggests that the fungus possesses numerous mechanisms to adapt to this
diversity of host sites, a versatility undoubtedly controlled by
differential gene expression. Much investigative effort has focused on
defining molecular mechanisms C. albicans uses for
growth and pathogenesis. One attribute of the fungus that is positively
correlated with pathogenicity is adherence (reviewed in reference
7). Adherent strains of C. albicans
are more virulent than those with a less-adhesive nature. Additionally,
a hierarchy exists among Candida species, with the more
frequently isolated pathogenic species exhibiting greater adhesive
capacity (reviewed in reference 7). Adherence of
C. albicans to host surfaces is also involved in the
process of colonization, which may occur without accompanying
pathogenesis. Investigations to understand C. albicans
adhesion have involved characterization of the cell surface, since this
is the initial point of contact between fungus and host (reviewed in
references 7, 9, 17, 23, and 29).
Adherence of C. albicans to numerous cell types,
cellular components, and nonliving substances has been examined to
further define adhesive relationships. Numerous obstacles exist to
hamper the study of C. albicans adhesion, including widely noted growth-medium-dependent effects and differences between C. albicans strains tested in the same assay (reviewed
in references 15, 30, and 45).
Despite these obstacles, several C. albicans molecules
involved in adhesive interactions have been identified (reviewed in
references 7, 9, 17 and 23).
Characterization of the C. albicans ALS gene family has
yielded data that address the major themes discussed above. The first gene in the ALS family, ALS1, was isolated in
a differential screen to identify hypha-specific genes
(26). Although subsequent studies demonstrated that
ALS1 is not strictly hypha-specific, its sequence has
significant identity with the sequence of AG
1 from
Saccharomyces cerevisiae, which encodes
-agglutinin, a
cell-surface adhesion glycoprotein that facilitates contact between
haploid cells during mating (19, 37). Because C. albicans has not been observed to undergo meiosis or mating, it
may be less likely that the function of Als1p is directly analogous to
that of Ag
1p (26). However, conservation between
sequences required for the adhesive function of
-agglutinin and
those at the N terminus of Als1p raised the intriguing possibility that
Als1p is an adhesion glycoprotein (26). Data supporting this
conclusion have been published recently (16, 18).
In addition to its potential to encode an adhesion glycoprotein, other
features of ALS1 prompted further study. ALS1
encodes a central domain of tandemly repeated copies of a highly
conserved 108-bp sequence that, when translated, predicts a highly
conserved 36-amino-acid motif (26). The tandem-repeat
sequence hybridizes to several genomic fragments from C. albicans, suggesting that ALS1 belongs to a gene family
(26). The existence of a gene family defined by the
tandem-repeat-hybridizing fragments was demonstrated by the
characterization of ALS3 (25). The size of the
ALS family is difficult to estimate because of the presence of additional tandem-repeat-hybridizing fragments and of other genomic
sequences that hybridize to a probe derived from the 5' end of
ALS1 (25, 26).
Experiments to characterize the ALS genes and to
understand their regulation were initially undertaken to lay the
groundwork for studying Als protein function in C. albicans. Studying Als protein function in C. albicans is challenging because, assuming redundancy of
function among proteins in the family, creation of a truly null mutant
requires characterization of the entire family and disruption of many
genes. We reasoned that the number of gene disruption steps could be
reduced by knowing which genes were expressed under a particular growth
condition. Combining a particular growth condition with specific
disruptions could effectively create a null mutant. Studies of
ALS gene regulation demonstrated that ALS1 and
ALS3 are differentially expressed (25, 26).
ALS1 expression in vitro is regulated by components of growth media, and ALS3 is hypha-specific (25,
26). In addition, expression of ALS1 was shown to vary
among strains of C. albicans (25).
In this study, we present data to further characterize the
ALS genes and their encoded proteins. Two new genes,
ALS2 and ALS4, are described. Similar to
previously characterized ALS genes, ALS2 and
ALS4 are shown to be differentially regulated. Comparison of
ALS gene sequences yielded a generalized ALS gene
structure that fits another C. albicans gene,
ALA1 (18). Here, we recognize the place of
ALA1 in the ALS family. Analysis of sequence
features of the five predicted Als proteins suggests that they are
localized on the C. albicans cell surface, a property
demonstrated by indirect immunofluorescence with an anti-Als antiserum.
Taken together, the data presented here demonstrate that the
cell-surface-localized Als proteins could account for a significant
portion of the strain- and growth-medium-dependent differences in
adhesion commonly noted in the C. albicans literature.
 |
MATERIALS AND METHODS |
Media and strains.
All standard growth media and strains
were described previously (25, 26). C. albicans B311 used in this study was purchased from the American
Type Culture Collection; other isolates of B311 used in previous
studies were not used here.
Library screening and DNA sequencing of ALS
genes.
Construction of the fosmid library and PCR screening with
primers specific for the consensus tandem-repeat sequence were
described previously (25). Fosmids that were positive in the
PCR screen were grouped on the basis of PCR products (25); a
representative fosmid was chosen from each group for subcloning and DNA
sequencing of each ALS allele. Fosmids chosen were 19F-1
(ALS2-1), 20F-3 (ALS2-2), 20E-6
(ALS4-1), and 29F-9 (ALS4-2). These fosmids were purified and digested with a variety of restriction enzymes. Southern blots of these digests were probed with an 870-bp KpnI
fragment from ALS1 that encodes only tandem-repeat sequences
(26) to identify fragments likely to encode related
ALS genes. These fragments were subcloned into pUC vectors
(57) and transformed into Escherichia coli
DH5
MCR (Gibco BRL). Plasmid purification and DNA sequencing were
conducted as described previously (26). DNA sequencing of
the tandem-repeat regions of ALS genes was limited to that required to determine that the tandem repeats conformed to the consensus pattern derived from ALS1 and that the
tandem-repeat domain did not encode anything besides head-to-tail
copies of the 108-bp sequence. This was accomplished with a combination of repeat-region subclones and production of nested deletions with a
double-stranded nested deletion kit (Amersham Pharmacia Biotech).
Sequences were reported as domains 5' and 3' of the tandem-repeat
domain. Both alleles of ALS2 and ALS4 from
C. albicans 1161 were sequenced and deposited
separately. Accession numbers for other sequences discussed here
include L25902 (ALS1 [26]), U87856
(ALS3 [25]), and AF025429
(ALA1/ALS5 [18]).
ALS2- and ALS4-specific probes.
A
164-bp fragment located immediately 3' of the tandem-repeat domain was
amplified by PCR and found to detect both ALS2 and ALS4. This PCR fragment was amplified with the forward
primer 5' TCCGAGTCCATTCCAGTACTAA 3' and the reverse primer
5' GTTACAGCATCACTAGAAGGAATATC 3'. The standard PCR for these
primers and others described below included 1 µM (each) primer, 0.2 mM (each) deoxynucleoside triphosphate, 1.5 mM MgCl2, 1×
Promega PCR buffer, 2.5 U of Promega Taq DNA polymerase, and
10 to 100 ng of template DNA.
Since there was a high degree of identity between ALS2 and
ALS4 in the domain 3' of the tandem repeats, this region
could not be exploited to define gene-specific probes as it had been for ALS1 (26) and ALS3
(25). Because of the high degree of nucleotide sequence
conservation between all ALS genes within the domain 5' of
the tandem repeats, ALS2 and ALS4 could be
specifically detected only with oligonucleotide probes. The resulting
ALS2-specific probe, 5' TAGTTCCTTACAAAGTAAGCCGTTCAATTT
3' (located at nucleotide 897 in the ALS2-coding
region), and the ALS4-specific probe 5' CGCGGCTTCTGTTGATGACTCATTTACTCATACT 3' (located at nucleotide 900 of the ALS4-coding region) were used in Southern blotting.
The reverse complement of each probe was synthesized for use in
Northern blotting as described below.
ALS5 probe.
A probe encoding only tandem-repeat
sequences from ALA1/ALS5 (18) was synthesized by
PCR with the forward primer 5' GGTACAAGTTCCACTGCCAAA 3' and
the reverse primer 5' AAGACAGTTCTTCCAATGGATCA 3'. These primers amplified two products from genomic DNA of C. albicans 1177, one at approximately 200 bp and the other at
approximately 680 bp. These two products were presumably due to
amplification of tandem-repeat regions from each allele of
ALS5 in this strain. The 680-bp fragment was cloned into
pCR2.1 (Invitrogen) and transformed into E. coli TOP10F'
cells (Invitrogen). The DNA sequence of the cloned PCR fragment
conformed to the consensus tandem-repeat sequence of ALS5
(18).
Nucleic acid blots.
Southern blotting was performed as
described previously (26) with the digoxigenin
nonradioactive nucleic acid labeling and detection system (Boehringer
Mannheim). Blots probed with the ALS1 or ALS5
tandem-repeat sequence were hybridized at 65°C overnight. Blots were
washed in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-0.1% sodium dodecyl sulfate (SDS) at room temperature for 30 min and then with 0.5× SSC-0.1% SDS at 65°C for 1 h.
Cultures of strains SC5314 and 3153A were used to demonstrate the
growth-stage-associated expression of
ALS4 on Northern
blots.
Cells from an overnight YPD (yeast extract, peptone, dextrose)
culture were washed twice in sterile water and inoculated into
500 ml
of fresh YPD at 5 × 10
6 cells/ml. An aliquot of this
culture was removed to extract total
RNA for the 0 h time point.
Cells for RNA preparation were washed
twice with
diethylpyrocarbonate-water, flash frozen in an ethanol
dry-ice bath,
and stored at

80°C until RNA was extracted. The
freshly inoculated
YPD culture was incubated at 30°C, with shaking
at 200 rpm. Samples
were removed every hour for 8 h and processed
for RNA extraction
as described above. Three or four independent
cell counts were
performed at each time point to construct a growth
curve.
Total RNA extraction, formaldehyde gel electrophoresis, and Northern
blotting were performed as described previously (
25).
Fifty
micrograms of total RNA was loaded into each gel lane.
ALS4-specific
message was detected with the end-labelled
ALS4-specific oligonucleotide.
Hybridization with
oligonucleotide probes followed the method
of Sundstrom et al.
(
52). Equal loading of total RNA on Northern
blots was
evaluated with a fragment from the
C. albicans TEF1 gene (
52) as previously described (
26).
Production of anti-Als antiserum.
Hyperimmune anti-Als serum
raised in a New Zealand White rabbit was a gift from George Livi
(SmithKline Beecham Pharmaceuticals). The anti-Als serum was raised
against four 10-mer peptides derived from the N-terminal domain of
Als1p (26). These peptides were chosen because they were
likely to be in a hydrophilic, surface-exposed region of the mature,
folded protein as predicted by secondary-structure algorithms
(14). Peptides from the N-terminal region of Als1p were
selected because this portion of the protein was predicted to be
relatively free of glycosylation compared to other regions of the
protein (26). The peptides selected were GWSLDGTSAN (amino acids 53 to 62), FYSGEEFTTF (amino acids 98 to 107), TGSSTDLEDS (amino
acids 139 to 148), and NTVTFNDGDK (amino acids 156 to 165). These
peptides were linked to keyhole limpet hemocyanin (KLH) and combined in
equal quantities prior to emulsification in Freund's complete adjuvant
(Sigma). The emulsion was injected into the rabbit at multiple
subcutaneous sites. A blood sample was collected from the marginal ear
vein 14 days later. A booster immunization was administered 4 weeks
after the initial immunization. The booster immunization was performed
with the mixture of four KLH-linked peptides emulsified in incomplete
Freund's adjuvant (Sigma). A blood sample was collected 14 days after
the booster immunization, and the anti-Als titer was assayed on a
Western blot of a heterologously produced soluble N-terminal fragment
of Als1p (see below). Four total-booster injections were performed,
with the anti-Als titer increasing following each round. Increasing
titer was judged by increasing dilutions of serum required to obtain an
equivalent Western blot signal. Serum collected from the rabbit was
stored in small aliquots at
80°C. Preimmune serum collected
from the same rabbit in which the anti-Als serum was raised and a
commercially purchased anti-KLH serum (ICN) were both utilized as
negative controls.
Indirect immunofluorescence of C. albicans
cells.
Cells of strain SC5314 were grown in YPD until they reached
late stationary phase; at this stage of growth, cultures typically have
a density of approximately 5 × 108 cells/ml. Cells
from this culture were washed twice in phosphate-buffered saline (PBS)
(per liter: 10 g of NaCl, 0.25 g of KCl, and 1.43 g of
Na2HPO4 [pH 7.2 to 7.3]) and counted. A fresh
culture of RPMI 1640 (catalog no. 11875-085; Gibco BRL) was inoculated
at a density of 5 × 106 cells/ml. This culture was
incubated at 37°C and 120 rpm for 1 h 45 min. One hundred
microliters of this culture was spread into an area of a cleaned glass
slide that had been delineated by etching with a diamond pen. Slides
were washed thoroughly in PBS before we proceeded. Slides were blocked
with 200 µl of 1.5% normal goat serum (Jackson Research
Laboratories) diluted in PBS and incubated for 10 min at room
temperature in a humid chamber. Excess normal serum was drained from
slides, and 200 µl of a primary antibody solution was added. Two
different primary antisera were used, a 1:100 dilution of the anti-Als
serum purified on a protein G column according to the manufacturer's
instructions (MAbTrap G II column; Amersham Pharmacia Biotech) and a
1:500 dilution of the preimmune serum from the rabbit in which anti-Als
serum was raised. Immunoglobulin G (IgG) concentrations of these
preparations were roughly equivalent; a lower dilution of the
protein-G-purified serum was used to account for the dilution that
occurs during the purification procedure. Primary antiserum was
incubated on slides for 1 h at 4°C in a humid chamber. Slides
were washed thoroughly in ice-cold PBS. The secondary antibody,
fluorescein-isothiocyanate (FITC)-conjugated goat anti-rabbit IgG
(heavy plus light chains) (catalog no. 111-095-003; Jackson Research
Laboratories) was diluted 1:2,500 from a 0.75 mg/ml stock and incubated
on slides for 1 h at 4°C in a humid chamber. Slides were washed
thoroughly in ice-cold PBS and stored in darkness at 4°C until they
were viewed later the same day.
Immunofluorescence images were obtained with an Olympus BX60
fluorescence microscope with an oil immersion lens at approximately
400× magnification. Images were captured with a Photometrics Ltd.
system consisting of a charge-coupled device camera (model CH250),
an
electronic unit (model CE 200A, equipped with a 50-Hz 16-bit
A/D
converter), and a controller board (model NU 200). Images
were acquired
and evaluated with Adobe Photoshop software and
a Macintosh Quadra 840 AV computer (Apple Computer, Inc.).
Heterologous expression of an N-terminal fragment of Als1p in
S. cerevisiae.
A PCR product encoding the N-terminal 433 amino acids of Als1p was produced with the forward primer 5'
CCCCCCCATGGTTCAACAATTTACATTGTTATTCCTATA 3' and the reverse primer
5' CCCCCGTCGACCAGTGGAACTTGTACCACCACTGTGTCA 3'. The PCR
product derived from C. albicans B311 genomic DNA was
digested with NcoI and SalI and cloned into the
NcoI-SalI-digested S. cerevisiae
expression vector p138NB. Features of this vector have been described
previously (38, 42). Briefly, the expression vector contains
the TRP1 selectable marker and partial 2µm sequences for
maintenance at high copy number. Expression is driven by the copper-inducible CUP1 gene promoter. A multiple cloning site
is present in the vector downstream of the CUP1 promoter and
upstream of the CYC1 transcription terminator. Shuttle
vector functions allowed a correct construct, pLH109, to be selected in
E. coli DH5
MCR (Gibco BRL). Plasmid pLH109 was
transformed into the S. cerevisiae strain YPH 274 (a/
ura3-52/ura3-52
lys2-801amber/lys2-801amber
ade2-101ochre/ade2-101ochre
trp1-
1/trp1-
1 his3-
200/his3-
200
leu2-
1/leu2-
1 [50]). The resulting S. cerevisiae strain was grown in synthetic complete medium
without tryptophan (22). A 500-ml culture was grown to late stationary phase at 30°C. Cells were harvested from this culture, washed twice in fresh synthetic complete medium without tryptophan, and resuspended in 30 ml of fresh medium. Expression from
the CUP1 promoter was induced by the addition of 150 µM
CuSO4. Induced cells were grown for 4 h at 30°C with
200 rpm shaking. Cells were collected by centrifugation, and the
resulting culture supernatant was brought to 70% saturation with
ammonium sulfate to precipitate proteins, including the secreted
N-terminal portion of Als1p. The ammonium sulfate precipitation was
incubated overnight at 4°C on a rocker platform and then harvested by
centrifugation at 15,000 rpm (31,000 × g) for 30 min
in a Beckman JA-17 rotor. Supernatant was decanted, and the precipitate
was dissolved in PBS. The dissolved precipitate was thoroughly dialyzed
against PBS in 12,000- to 14,000- molecular-weight-cutoff dialysis
tubing (Spectrum Laboratories, Inc.). The dialysate was concentrated in
a Centricon-10 unit (Amicon, Inc.) and run on a 12.5% Tris-glycine polyacrylamide gel (31). S. cerevisiae YPH274
transformed with blank p138NB plasmid was processed concurrently as a
negative control. Coomassie blue R-250 (Sigma) and silver staining
(Bio-Rad) indicated the presence of a single protein band at
approximately 65 kDa in samples from YPH274(pLH109) that was not
present in YPH274(p138NB). This band was presumed to be the N-terminal
portion of Als1p. Its identity was confirmed by Western blotting with the anti-Als antiserum described above.
N-terminal amino acid sequencing of the Als1p-derived
fragment.
The 65-kDa band in the supernatant of the YPH274(pLH109)
culture was well separated from the sparse number of protein bands present on the acrylamide gel. To determine the N-terminal amino acid
sequence of the 65-kDa Als1p fragment, a 12.5% polyacrylamide gel of
supernatant sample was run. Proteins from the gel were electroblotted
to a polyvinylidene difluoride membrane (Gelman Sciences, Inc.) with a
10 mM CAPS [3-(cyclohexylamino)-1-propanesulfonic acid] (Sigma) (pH
11.0)-10% methanol buffer in a Bio-Rad TransBlot apparatus. The
polyvinylidene difluoride membrane was rinsed thoroughly with deionized
water and stained with 0.2% Coomassie blue R-250 in 45%
methanol-10% acetic acid. The membrane was destained with 50%
methanol-1% acetic acid and air dried, and the Als1p-derived fragment
was excised with a new razor blade. N-terminal amino acid sequencing
was performed by the Iowa State University Protein Facility with a
model 492 Procise protein sequencer and a model 140C analyzer (Applied
Biosystems, Inc.).
Nucleotide sequence accession numbers.
Both alleles of
ALS2 and ALS4 from C. albicans
1161 were sequenced and deposited separately. GenBank accession numbers
are AF024580 (5' domain) and AF024581 (3' domain) (ALS2-1), AF024582 and AF024583 (ALS2-2), AF024584 and AF024585 (ALS4-1), and AF024586 and AF024587 (ALS4-2).
 |
RESULTS |
ALS2 and ALS4 complete the set of genes
that hybridize with the ALS1 tandem-repeat probe.
An
870-bp KpnI fragment derived from within the tandem-repeat
domain of ALS1 hybridizes with several genomic fragments
from C. albicans and C. stellatoidea;
the number of hybridizing fragments depends upon the strain examined
(26). The 10 copies of the 108-bp tandem-repeat element from
ALS1 in strain B792 were aligned to derive a consensus
sequence (26). PCR primers based on the most-conserved
regions of the tandem-repeat sequence were used to screen a fosmid
library from C. albicans 1161 (25). By this technique, fosmids were noted to yield different PCR product patterns and were grouped accordingly (25). Characterization of a
representative fosmid from one of the groups yielded ALS3
(25); fosmids from the other groups encoded alleles of two
other ALS genes, designated ALS2 and
ALS4. Restriction enzyme analysis and hybridization with ALS-gene-specific probes indicated that ALS2 and
ALS4 accounted for the remaining fragments that hybridize
with the ALS1 tandem-repeat probe in genomic DNA from
C. albicans 1161 (Fig.
1). A similar analysis with 12 C. albicans and two C. stellatoidea
strains indicated that, in each strain, all four ALS genes
are present and account for all of the restriction fragments that
hybridize with the ALS1 tandem-repeat probe (data not
shown). Varying numbers of tandem-repeat-hybridizing fragments
originally noted in each strain (26) were due to differences between allelic fragments encoding the same gene and to comigration of
larger restriction fragments (data not shown).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
Designation of genomic DNA fragments that encode
ALS genes. Southern blots of BglII- or
HindIII-digested genomic DNA from C. albicans 1161 were hybridized with an 870-bp KpnI
fragment from ALS1 that contained only tandem-repeat
sequences (26). ALS alleles corresponding to each
of these restriction fragments were identified on separate blots with
gene-specific probes developed previously (25, 26) or in
this study. Allelic fragments were deduced by data from several
experiments and sources, including physical mapping of C. albicans chromosomes (11, 48), restriction mapping of
specific fosmid clones, DNA sequence analysis, and gene regulation
studies (25, 26). Molecular size markers (in kilobases) are
included between the blots.
|
|
The DNA sequence was derived for both alleles of
ALS2 and
ALS4.
ALS2 and
ALS4 conformed to the
basic three-domain structure
of
ALS genes, which includes a
central domain of varying numbers
of copies of a tandemly repeated
108-bp sequence, a 5' domain
that is approximately 1.3 kb in length and
conserved between
ALS genes, and a 3' domain that is
variable in length and sequence
(
25). Characterization of
fosmids encoding
ALS2 and
ALS4, as
well as
physical mapping efforts in this lab and others, suggested
that
ALS2 and
ALS4 were located approximately 70 kb
from each
other on chromosome 6,
SfiI fragment C (data not
shown;
48).
Allelic differences have been noted previously for other
ALS
genes, although this has been mainly in the tandem-repeat region,
where
alleles have been demonstrated to encode different numbers
of
head-to-tail copies of the 108-bp motif (
26) (Table
1).
In the current study, alleles of
ALS2 and
ALS4 were sequenced
to study
conservation of nucleotides in the non-tandem-repeat
domains. In these
other two domains, alleles of
ALS2 and alleles
of
ALS4 were more than 97% identical in nucleotide sequence
(see
below). Although the complete tandem-repeat region in both
ALS2 and
ALS4 was not sequenced, sufficient
sequencing was completed
in each allele to determine that the
tandem-repeat region conformed
to the consensus tandem-repeat sequences
derived for
ALS1 and
ALS3 and to confirm that
only tandem-repeat sequences were present
(data not shown). Sequencing
of large regions of tandemly repeated
DNA has been omitted in other
studies such as the
S. cerevisiae genome project
(
28).
Designation of C. albicans ALS5 and its place in
the ALS family.
Characterization of ALS1,
ALS2, ALS3, and ALS4 yielded a
generalized three-domain structure for ALS genes. Another
recently characterized C. albicans gene, called
ALA1 (18), also fits this basic motif and belongs
to the ALS family. Because the name ALA1 has been
previously used to denote an alanyl tRNA synthetase in S. cerevisiae (44), and because C. albicans nomenclature follows the S. cerevisiae
precedent (48), we propose that the gene described by Gaur
and Klotz (18) be called ALS5.
ALS5 was not identified in the original screening of genomic
DNA by hybridization with the
ALS1 tandem-repeat probe.
Therefore,
although both genes encode a domain of tandem repeats, the
exact
tandem-repeat sequences were sufficiently dissimilar to escape
detection by cross-hybridization under the experimental conditions
employed. Comparison of the consensus tandem-repeat sequences
of
ALS1 (
26) and
ALS5 (
18)
indicated matches between only
39% of the nucleotides (data not
shown). Because hybridization
between two sequences depends on matches
between individual tandem-repeat
copies rather than an idealized
consensus, Southern blotting was
done to see if any genomic fragments
hybridized with both probes.
An
ALS5 tandem-repeat probe was
amplified by PCR with primers
that flank the tandem-repeat region in
this gene (
18). The DNA
sequence of this probe fragment
indicated that it closely matches
the consensus sequence of the tandem
repeats of
ALS5 in the clinical
isolate used by Gaur and
Klotz (data not shown;
18). Southern
blots of
BglII-digested genomic DNA from
C. albicans
and
C. stellatoidea strains indicated that the
ALS1 tandem repeats hybridized to a
different set of genomic
fragments than did the
ALS5 tandem repeats
in most strains
(Fig.
2). Based on this result, the small
number
of fragments of similar size that were detected with both probes
most likely encode different genes. Additional
ALS genes
have
been isolated which possess the general
ALS
three-domain structure
but which have more sequence similarities to
ALS5 than to
ALS1.
Analysis of these gene
sequences suggested that variability in
the tandem-repeat sequences was
a potential criterion for the
division of the
ALS family
into subfamilies (
24).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Southern blots of BglII genomic DNA fragments
hybridized with ALS1 and ALS5 tandem-repeat
probes. Genomic DNA from a variety of C. albicans and
C. stellatoidea strains was digested with
BglII, blotted and probed with an 870-bp KpnI
ALS1-tandem-repeat-specific probe (left panel). The blot was
stripped and reprobed with a PCR-amplified ALS5
tandem-repeat fragment PCR amplified from C. albicans
1177 (right panel). Molecular size markers (in kilobases) are indicated
at the left for each blot.
|
|
Sequences in the N-terminal domain of Als proteins are
highly conserved and encode a secretory signal peptide.
Sequences N-terminal of the tandem-repeat domain were highly
conserved in each predicted Als protein, with amino acid identity between different proteins ranging from 68 to 86% (Fig.
3). Identity of the nucleotide sequences
encoding the N-terminal domain was 73 to 90%. At the start of each
coding region was a hydrophobic sequence with hallmarks of a secretory
signal peptide (54). To test whether the hydrophobic N
terminus functioned as a signal sequence, a construct expressing the
N-terminal 433 amino acids of Als1p under control of the
CUP1 promoter was transformed into S. cerevisiae
(see Materials and Methods). Supernatants from cultures of the
CuSO4-induced construct and a control strain harboring the
blank expression plasmid were run on SDS-polyacrylamide gels (31). Coomassie blue and silver staining of these gels
indicated that a major protein species was present at approximately 65 kDa in supernatant from cells with the Als1p construct and absent from
cells transformed with blank vector (data not shown). N-terminal amino acid sequencing of the 65-kDa protein yielded the sequence Lys-Thr-Ile-Thr and indicated true secretion of the N-terminal Als1p
fragment with resultant loss of the first 17 amino acids (Fig. 3).
Cleavage following Ala17 was correctly predicted by the Signalase
program (21), which is based on the predictive algorithms of
von Heijne (54) and identifies sites for signal peptide
cleavage. Analysis of the other Als protein sequences with the
Signalase program predicted signal peptide cleavage at the same site,
which was conserved in each of the Als amino acid sequences
characterized to date (Fig. 3). Because signal sequences have been
shown to be processed similarly in S. cerevisiae and C. albicans (39), it is likely that the same
processing site is utilized by C. albicans.

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 3.
Alignment of N-terminal amino acid sequences predicted
from genes in the ALS family. Amino acid sequences were
predicted by the translation of ALS gene sequences 5' of the
start of the tandem-repeat domain. Sequences included are Als1p
(26), Als2p and Als4p (this study), Als3p (25),
and Als5p/Ala1p (18). Sequences were aligned with default
parameters of the PILEUP program of Genetics Computer Group software
(14). A consensus sequence (Cons), indicating amino acids
conserved in all sequences, is provided below the alignment. The
vertical line (designated SSC) between residues 17 and 18 denotes the
site of signal sequence cleavage demonstrated biochemically for Als1p
and predicted by computer algorithm to be conserved for the remaining
proteins. Boxed regions labelled 1, 2, 3, and 4 correspond to the four
10-mer peptides from Als1p used to raise the rabbit polyclonal anti-Als
antiserum used in indirect immunofluorescence studies. The boxed Als2p
and Als4p sequences (labelled Probe) correspond to the region in the
nucleotide sequence from which ALS2- and
ALS4-specific oligonucleotides were derived. Boxed sequences
between alleles of Als2p or Als4p indicate nonconserved amino acid
sequences predicted from allelic nucleotide sequences. Consensus N
glycosylation sites (2) are underlined in the Als2p
sequences at positions 253 and 315. All CUG codons have been changed
from Leu to Ser (46, 55).
|
|
The N-terminal domain of the Als protein molecule, particularly within
the first 330 amino acids, was predicted to be relatively
free of
glycosylation. In this region, all predicted Als protein
sequences,
with the exception of Als2p, lacked consensus sequences
for N
glycosylation (Fig.
3). After the first 330 amino acids,
each predicted
Als protein had a threonine-rich region, raising
the possibility that O
glycosylation may be added; the increased
frequency of serine and
proline residues also supported this possibility
(Fig.
3).
Sequences C-terminal of the tandem-repeat domain are divergent but
have a serine-threonine-rich composition.
Of the three domains
present in Als proteins, the domain C-terminal of the tandem repeats
was the least conserved across the family. This domain varied in
sequence and length in the predicted Als proteins but exhibited similar
amino acid sequence compositions (Table 1). The serine-threonine
richness of this domain was consistent with the possibility of abundant
O glycosylation (27). This feature, along with the presence
of consensus sites for N glycosylation, predicted that the C-terminal
domain was heavily glycosylated (Table 1). Both of these features were
also observed in the tandem-repeat domain, which was similarly
predicted to be heavily glycosylated.
Although sequences of the C-terminal domain were divergent, those
residues within 50 amino acids of the stop codon were highly
conserved
(Fig.
4). Within these conserved residues
was a hydrophobic
region with hallmarks of the consensus site for
glycosylphosphatidylinositol
(GPI) addition. The features of a GPI
addition site have been
well characterized (reviewed in references
8 and
12); following
these rules,
cleavage at the conserved Gly or Ser was predicted
(Fig.
4). Yeast
proteins to which GPI is added can be localized
to either the cell
membrane or, after truncation of the GPI, cross-linked
in the cell wall
(reviewed in reference
8). Analysis of amino
acid
sequences predicted from the
S. cerevisiae genome sequencing
project identified a dibasic motif immediately preceding the GPI
attachment site that is present in proteins localized to the cell
membrane (
8). The lack of this dibasic motif in the Als
protein
sequences (Fig.
4) suggested that if
C. albicans followed the
same rules as
S. cerevisiae, Als
proteins were likely to be localized
in the cell wall.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of the C-terminal amino acid sequences of Als
proteins. Approximately the last 50 amino acids of each predicted Als
protein sequence were aligned, to demonstrate sequence conservation in
this region. A consensus sequence indicating amino acids conserved in
every protein is indicated below the multiple alignment. The putative
GPI addition sites are indicated by arrows. The larger arrow over the
Gly residue suggests that this is the more likely GPI attachment
site.
|
|
Although the C-terminal domain was the most highly divergent of the
three
ALS domains, the C-terminal domains of Als2p and
Als4p
and the nucleotide sequences which encode them were more
than 95%
identical. Multiple alignment of the nucleotide sequences
of the
ALS2 and
ALS4 alleles indicated that only 3.9%
of the sequence
positions were mismatched.
ALS2-1 and
ALS4-1 each had a small
gap; in each case, this gap was
apparently due to duplication
of a trinucleotide sequence in the other
allele. Allelic sequences
were also examined;
ALS2 alleles
had 2.8% of sequences mismatched,
whereas
ALS4 sequences
varied in only 0.5% of nucleotides. The
mismatch between allelic
sequences in the 5' domain was slightly
less, with 0.3% variation
between the
ALS2 alleles and 0.4% between
alleles of
ALS4. The nucleotide sequence identity between the
3'
domains of
ALS2 and
ALS4 extended beyond the
coding region;
a region approximately 500 bp 3' of each coding region
was sequenced
and found to be over 95% identical for each gene (data
not shown).
Cell-surface localization of Als proteins by indirect
immunofluorescence.
The predicted amino acid sequences of the Als
proteins suggested that they were localized on the cell surface.
Features such as an N-terminal signal peptide, a C-terminal GPI
addition site, repeated sequences, and C-terminal regions rich in
serine and threonine have all been noted in other yeast cell-surface
proteins (reviewed in reference 8).
Cell-surface localization of Als proteins was demonstrated
by indirect immunofluorescence with a rabbit polyclonal antiserum
raised against four KLH-linked 10-mer peptides from Als1p.
Subsequent characterization of additional ALS genes
indicated that the 10-mer peptide sequences were highly conserved in
the predicted amino acid sequences for other proteins of the Als family
(Fig. 3). Recognition of Als1p and Als3p by the anti-Als antiserum was
demonstrated by Western blotting of heterologously produced protein
fragments (data not shown); other Als proteins remain to be tested.
For immunofluorescence studies, yeast-form cells were grown
in YPD medium and transferred to RPMI 1640 to induce germ tube
formation. Both the mother yeast and germ tube stained with the
anti-Als antiserum (Fig.
5). The
specificity of this staining
was demonstrated in competition
experiments in which staining
of both the mother yeast and the germ
tube was blocked by the
addition of soluble N-terminal Als1p fragment
(data not shown).
C. albicans cells treated either with
preimmune serum from the
rabbit in which the polyclonal serum was
raised (Fig.
5F) or with
commercially purchased anti-KLH antiserum in
place of the anti-Als
serum did not stain (data not shown).

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 5.
Indirect immunofluorescence of C. albicans SC5314 germ tubes. YPD-grown C. albicans
cells of strain SC5314 were induced to form germ tubes by inoculation
into RPMI 1640 medium. Panels A, C, and E are light micrographs
corresponding to the fluorescent micrographs in panels B, D, and F,
respectively. Cells in panels B and D were treated with anti-Als
antiserum followed by FITC-labelled goat-anti-rabbit IgG. Cells in
panel F were stained with preimmune serum from the same rabbit in which
the anti-Als serum was raised, followed by staining with the
FITC-labelled secondary antiserum. The arrow in panel B indicates a
large mother yeast cell that has lost its fluorescence. Arrows in panel
D indicate small mother yeast cells for which fluorescence is still
visible.
|
|
Although YPD-grown yeast forms stained with anti-Als serum (data not
shown), this staining intensity diminished with elongation
of the germ
tube (Fig.
5B and D). The germ tube length which corresponded
to the
loss of mother yeast fluorescence differed with the size
of the mother
yeast cell (Fig.
5A and B [arrow] versus Fig.
5C
and D [arrows]).
An additional experiment was performed in which
cells were collected
for staining at 30-min intervals following
the induction of germ tube
formation. Decreasing fluorescence
was observed with germ tube
elongation for both small and large
yeasts, with the same final result
of nonfluorescent mother yeast.
However, a longer time was required to
effect equivalent results
from small mother yeasts than from larger
yeast cells (data not
shown). Results from the indirect
immunofluorescence experiments
indicated that Als proteins were
localized on the
C. albicans cell surface and raised
interest in the distribution of Als proteins
during the yeast-to-hypha
conversion.
Variability in ALS gene size and expression
pattern.
It is well documented that the sizes of ALS
genes in any C. albicans strain are highly variable
(25, 26). In certain strains, alleles of a given
ALS gene produce different-sized proteins due to variation
in the numbers of tandem-repeat copies present in each allele (Table
1). Also, certain Als proteins are likely to be larger than others,
with Als1p in one strain, for example, being twice the size of Als1p in
another strain (26).
Variability also exists within the
ALS family with respect
to patterns of gene expression. Previous work demonstrated the
differential expression of
ALS1 (
26) and the
hypha-specific
expression of
ALS3 (
25). Northern
analysis established that
ALS4 expression was correlated
with the growth phase of a
C. albicans culture. This
effect was first noted in a pilot experiment in
which
C. albicans cells from an overnight YPD culture were subcultured
into
fresh media and incubated at 30°C with shaking at 200 rpm.
RNA was
analyzed at 3-h time points by Northern blotting with
an
ALS4-specific probe.
ALS4-specific message was
present except
when cells were in early- to mid-log phase (data not
shown). Cultures
were followed for 33 h, at which time
ALS4 message was abundant
(data not shown). To more
carefully analyze the time period in
which
ALS4-specific
message was absent, the experiment was repeated
with 1-h time intervals
(Fig.
6). A Northern blot hybridized to
detect
ALS4-specific messages was deliberately overexposed
to
identify lanes in which
ALS4-specific message was absent
and to
pinpoint the time when the synthesis of
ALS4-specific
message
began (Fig.
6). Because the half-life of the
ALS4-specific RNA
was not known, it was unclear whether
signals present at the 0-,
1- and 2-h time points were due to new
synthesis or to dilution
and decay of message present in the
stationary-phase cells used
to inoculate the culture. Synthesis
of
ALS4-specific message began
during the fifth hour,
when cells reached mid-log phase, and increased
as the culture reached
stationary phase. In previous experiments,
the increase in
ALS4-specific signal continued as the culture
reached
stationary phase (data not shown). These experiments were
also done
with
C. albicans 3153A, and the same pattern of
expression
was noted (data not shown).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
ALS4 expression in YPD-grown C. albicans cells. Strain SC5314 was grown overnight in YPD; cells
from this culture were used to inoculate fresh YPD medium. Immediately
after inoculation (0 h) and at each hour for the next 8 h, an
aliquot of cells was removed. Cells were counted to generate a growth
curve (right panel) and harvested for RNA extraction and Northern
blotting with an ALS4-specific probe (left panel). A
fragment of the C. albicans TEF1 gene was used as a
control for equal loading of RNA.
|
|
In contrast to the definable pattern of
ALS4 expression,
ALS2-specific message was not detected in cultures grown
under a
wide variety of in vitro conditions, including all growth
stages
in YPD and YND (neopeptone substituted for peptone); RPMI
1640-induced
germ tubes and hyphae; Lee (
33) and Soll medium
(supplemented
Lee medium [
3]) at pHs 4.5, 5.5, 6.5, and 7.5; Emmons-modified
Sabouraud medium (
32) with various
carbon sources, including
dextrose, galactose, maltose, and sucrose;
and hyphal cells induced
by adding 10% serum to YPD, 10 mM imidazole
buffer (
49), and
PBS. Cells in these media were grown at
various temperatures,
including 25, 30, and 37°C.
C. albicans strains in these studies
included B311, B792, SC5314,
1177, 3153A, and WO-1. The lack of
detection of an
ALS2-specific message under so many in vitro conditions
suggested a number of possibilities, including the possibility
that
ALS2 was a pseudogene and the possibility that
ALS2 required
in vivo signals for expression.
 |
DISCUSSION |
PCR screening of a C. albicans fosmid library with
primers based on the consensus tandem-repeat sequence of
ALS1 yielded fosmids encoding ALS3
(25), ALS2, and ALS4. These genes
account for the ALS1-tandem-repeat-hybridizing fragments
detected in high-stringency Southern blots of C. albicans genomic DNA (26). An additional gene described
in the literature, ALA1 (18), also belongs in the
ALS family and is designated ALS5. Although
ALS5 encodes tandem repeats similar to those in
ALS1, there is sufficient nucleotide sequence divergence
between the two consensus repeat sequences that they detect different
genomic fragments on high-stringency Southern blots.
Sequences N-terminal of the tandem repeats are highly conserved in the
five aligned Als proteins; however, sequences C-terminal of the tandem
repeats are divergent. N-terminal hydrophobic sequences function as a
signal peptide which is cleaved following Ala17, a site conserved in
each Als protein. C-terminal conserved hydrophobic sequences within the
last 50 amino acids of each predicted Als protein have characteristics
of the site for GPI addition. These observations are consistent with
cell-surface localization of Als proteins, a feature demonstrated by
indirect immunofluorescence with an anti-Als serum. The anti-Als serum
stains both mother yeasts and germ tubes, with the intensity of
staining of the mother yeast diminishing as the germ tube elongates.
Analysis of expression patterns of the two newly characterized
ALS genes indicates that the expression of ALS4
is correlated with the growth phase of the culture. ALS2
message was not detected in vitro despite the fact that a wide variety
of growth conditions were tested. These data support previous
evidence that genes in the ALS family are differentially
regulated.
Als protein profile on the C. albicans cell
surface.
The profile of Als proteins on the C. albicans cell surface is highly variable and depends upon several
factors, including growth conditions and strain (Table 1) (25,
26). Indirect immunofluorescence experiments demonstrated
that the Als protein profile on the C. albicans surface
is dynamic. Both mother yeasts and germ tubes stain with an anti-Als
serum, and staining of the mother yeast diminishes with germ tube
elongation. Possible explanations for the diminishing fluorescence of
the mother yeast include migration of the Als proteins from the mother
yeast to the growing germ tube, masking of the Als protein antigens on
the mother yeast by synthesis of new cell wall material, and shedding
of the Als protein antigens into the culture medium. Migration of cell
wall material from mother yeast to germ tube is unlikely in light of data published by Staebell and Soll (51), which demonstrated growth of a germ tube predominantly by apical expansion. Masking of
cell-surface proteins by carbohydrate or by glycosylation of other
proteins has been discussed in the context of C. albicans cell-surface hydrophobicity (20, 41). Because
the N-terminal epitope recognized by the anti-Als antiserum is
predicted to be glycosylation free, it is unlikely that the epitope is
masked by the direct addition of carbohydrate. However, modification of
preexisting glycosylated cell-surface proteins or the production of new
ones might explain the diminished fluorescence of the mother yeast.
Another possible reason for the diminishing fluorescence of the mother
yeast is the shedding of antigens into the culture medium, a phenomenon
that is well documented (reviewed in reference 40).
High-molecular-weight mannoproteins within the range of sizes predicted
for Als proteins are among those shed (1, 40). Previous work
by Brawner and Cutler described a C. albicans
cell-surface antigen with the same pattern of expression we observed
with our anti-Als serum (4-6). Immunogold electron
microscopy with a monoclonal IgM indicated that the antigen studied by
Brawner and Cutler was associated with the outer flocculent layer of
the cell surface (4-6); they discussed shedding of the
antigen into the growth medium as an explanation for its diminished
intensity on the mother yeast during germ tube elongation.
Nature of the putative binding domain.
Als proteins were named
because of the similarities between predicted Als sequences and the
sequence of
-agglutinin of S. cerevisiae. Information
about the well-characterized
-agglutinin has provided numerous clues
about the localization and function of Als proteins (36).
The most-significant sequence identity between Als proteins and
-agglutinin exists between the first 300 amino acids of each protein
(26). Within this region,
-agglutinin has an
immunoglobulin fold structure that is characteristic of many different
cell adhesion molecules (10, 13, 35, 56). Because the Als
proteins have significant sequence similarity to Ag
1p across
domain-sized blocks, they are likely to have a three-dimensional
structure similar to that of
-agglutinin (34). This
observation implicates the first 300 amino acids of the Als protein N terminus as a putative binding domain. Examination of Cys
residues in the two sequences indicates that the six Cys residues in
the first 300 amino acids of
-agglutinin are conserved in the first
300 amino acids of all Als proteins; however, in this region, each Als
protein contains two additional Cys residues that are not found
in
-agglutinin. Conservation of the eight Cys residues in the
first 300 amino acids of each mature Als protein strongly suggests
structural similarity in this portion of each molecule. Additional
studies are planned to predict the structure of the putative binding
domain of Als proteins and to evaluate its relatedness to the
immunoglobulin fold.
The tandem-repeat region and C-terminal domain are predicted to be
highly N and O glycosylated. Because O glycosylation can
confer
a rigid structure on a given protein (
27), the tandem
repeats and C-terminal sequences are likely the means by which
the
putative binding domain is displayed on the cell surface.
Estimates of
protein length demonstrate that most Als proteins
could be localized in
the cell membrane or cell wall and still
display this binding domain on
the cell surface; shorter proteins,
such as Als3p (
25), may
require cell wall localization to expose
the putative binding domain on
the cell surface. While lack of
the dibasic motif suggests that Als
proteins are localized in
the cell wall, membrane localization cannot
be completely ruled
out, because the GPI addition site of
C. albicans Phr1p, which
is localized in the cell membrane, also
lacks the dibasic motif
(
47,
53). It is also possible that
not all Als proteins have
the same subcellular localization.
Als protein function.
The growing size of the ALS family
prompts questions about the function of the encoded proteins and
conservation of function between proteins in the family. Als protein
function was addressed by two recent studies in which S. cerevisiae was transformed with a C. albicans
library seeking C. albicans genes that could confer an
adhesive phenotype on the nonadherent S. cerevisiae. In the first study, expression of ALA1/ALS5 in S. cerevisiae conferred adherence to fibronectin, laminin, type IV
collagen, and buccal epithelial cells (18). In the second
study, the expression of ALS1 in S. cerevisiae
conferred adherence to endothelial cells and to cells from an
esophageal epithelial line (16). Conclusions drawn in both
these studies are consistent with our ideas about the function of
Als proteins. The nature of the adhesive interaction observed in these
studies, however, needs further clarification to determine whether
adhesion is due to the putative N-terminal binding domain or to
another portion of the molecule. One portion of the molecule with the
potential to mediate an adhesive effect is the region predicted to
be highly glycosylated. The effect of protein must be separated
from that of the likely carbohydrate in order to define the nature of
the adhesive interaction.
The availability of amino acid sequences for several Als proteins
allows initial speculation about the conservation of function
among
proteins in the family. Presumed adhesive function due to
extensive
glycosylation suggests that Als proteins require only
a sequence that
serves as the scaffold for the addition of carbohydrate;
this is
provided by the tandem-repeat and C-terminal domains which
are rich in
consensus N glycosylation sites and in serine and
threonine, which are
potential sites for the addition of O-linked
carbohydrate (
2,
27). The amino acid sequence of the C-terminal
domain is highly
variable between Als proteins, but each protein
has features conducive
to abundant carbohydrate addition. Adhesive
function due to an
N-terminal binding domain requires conservation
of sequence determining
similar structural features. This is observed
for each mature Als
protein, which has eight conserved Cys residues,
a similar N-terminal
domain length, and a high degree of sequence
identity. Of the five Als
protein sequences, Als4p is least like
the others in regard to its
N-terminal domain sequence, suggesting
that it is the least
likely to exhibit conserved function. More-meaningful
information
about conservation of function will be gained from
structural
predictions with even-less-similar sequences, such
as that of Als7p,
which is only about 50% identical to Als1p in
the N-terminal domain
(
24). Differential glycosylation at the
N terminus, which is
possible for Als2p (Table
1), could also
lead to alterations in
the three-dimensional structure of the
region and to
corresponding variations in function. Whether adhesive
function is due
to protein, carbohydrate, or both, proteins encoded
by the
differentially regulated, multigene
ALS family have the
potential to explain much of the strain- and
growth-medium-dependent
differences in adhesion commonly
observed for
C. albicans.
 |
ACKNOWLEDGMENTS |
We thank George Livi and Megan McLaughlin of SmithKline Beecham
Pharmaceuticals for their gift of the anti-Als antiserum, Steven Klotz
for making the sequence of ALA1 available to us prior to
publication, and Roberto Docampo and Hong-Gang Lu for the use of and
assistance with the fluorescence microscope and digital imaging
equipment. We also thank the Iowa State University DNA Sequencing and
Synthesis Facility for sequencing the ALS2 and ALS4 genes. L.L.H. is grateful to Allan Shatzman, George
Livi, Stewart Scherer, and Alan Myers for their support of studies of the ALS gene family; without their support, this work would
not have been possible.
This work was supported by Public Health Service Grant AI39441 (to
L.L.H.); by Cooperative State Research, Education and Extension, U.S.
Department of Agriculture, under project no. ILLU-70-0305 (to L.L.H.);
and by the University of Illinois Campus Research Board (to L.L.H.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Pathobiology, University of Illinois at Urbana-Champaign, 2522 VMBSB, 2001 S. Lincoln Ave., Urbana, IL 61802. Phone: (217) 333-5043. Fax: (217) 244-7421. E-mail: lhoyer{at}uiuc.edu.
 |
REFERENCES |
| 1.
|
Aguiar, J. M.,
F. Baquero, and J. M. Jones.
1993.
Candida albicans exocellular antigens released into a synthetic culture medium: characterization and serological response in rabbits.
J. Gen. Microbiol.
139:3005-3010[Abstract/Free Full Text].
|
| 2.
|
Bause, E.
1983.
Structural requirements of N-glycosylation of proteins.
Biochem. J.
209:331-336[Medline].
|
| 3.
|
Bedell, G. W., and D. R. Soll.
1979.
Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and -sensitive pathways for mycelium formation.
Infect. Immun.
26:348-354[Abstract/Free Full Text].
|
| 4.
|
Brawner, D. L., and J. E. Cutler.
1986.
Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans.
Infect. Immun.
51:327-336[Abstract/Free Full Text].
|
| 5.
|
Brawner, D. L., and J. E. Cutler.
1984.
Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody.
Infect. Immun.
43:966-972[Abstract/Free Full Text].
|
| 6.
|
Brawner, D. L., and J. E. Cutler.
1986.
Variability in expression of cell surface antigens of Candida albicans during morphogenesis.
Infect. Immun.
51:337-343[Abstract/Free Full Text].
|
| 7.
|
Calderone, R. A., and P. C. Braun.
1991.
Adherence and receptor relationships of Candida albicans.
Microbiol. Rev.
55:1-20[Abstract/Free Full Text].
|
| 8.
|
Caro, L. H. P.,
H. Tettelin,
J. H. Vossen,
A. F. J. Ram,
H. van den Ende, and F. M. Klis.
1997.
In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae.
Yeast
13:1477-1489[Medline].
|
| 9.
|
Chaffin, W. L.,
J. L. Lopez-Ribot,
M. Casanova,
D. Gozalbo, and J. P. Martinez.
1998.
Cell wall and secreted proteins of Candida albicans: identification, function, and expression.
Microbiol. Mol. Biol. Rev.
62:130-180[Abstract/Free Full Text].
|
| 10.
|
Chen, M.-H.,
Z.-M. Shen,
S. Bobin,
P. C. Kahn, and P. N. Lipke.
1995.
Structure of Saccharomyces cerevisiae -agglutinin.
J. Biol. Chem.
270:26168-26177[Abstract/Free Full Text].
|
| 11.
|
Chu, W.-S.,
B. B. Magee, and P. T. Magee.
1993.
Construction of an SfiI macrorestriction map of the Candida albicans genome.
J. Bacteriol.
175:6637-6651[Abstract/Free Full Text].
|
| 12.
|
Coyne, K. E.,
A. Crisci, and D. M. Lublin.
1993.
Construction of synthetic signals for glycosyl-phosphatidylinositol anchor attachment.
J. Biol. Chem.
268:6689-6693[Abstract/Free Full Text].
|
| 13.
|
de Nobel, H.,
P. N. Lipke, and J. Kurjan.
1996.
Identification of a ligand-binding site in an immunoglobulin fold domain of the Saccharomyces cerevisiae adhesion protein -agglutinin.
Mol. Biol. Cell
7:143-153[Abstract].
|
| 14.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 15.
|
Douglas, L. J.
1987.
Adhesion of Candida species to epithelial surfaces.
Crit. Rev. Microbiol.
15:27-43[Medline].
|
| 16.
|
Fu, Y.,
G. Rieg,
W. A. Fonzi,
P. H. Belanger,
J. E. Edwards, and S. G. Filler.
1998.
Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells.
Infect. Immun.
66:1783-1786[Abstract/Free Full Text].
|
| 17.
|
Fukazawa, Y., and K. Kagaya.
1997.
Molecular bases of adhesion of Candida albicans.
J. Med. Vet. Mycol.
35:87-99[Medline].
|
| 18.
|
Gaur, N. K., and S. A. Klotz.
1997.
Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins.
Infect. Immun.
65:5289-5294[Abstract].
|
| 19.
|
Hauser, K., and W. Tanner.
1989.
Purification of the inducible -agglutinin of S. cerevisiae and molecular cloning of the gene.
FEBS Lett.
225:290-294.
|
| 20.
|
Hazen, K. C., and B. W. Hazen.
1992.
Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans.
Infect. Immun.
60:1499-1508[Abstract/Free Full Text].
|
| 21.
|
Hegner, M.,
A. von Kieckebusch-Guck,
R. Falchetto,
P. James,
G. Semenza, and N. Mantei.
1992.
Single amino acid substitutions can convert the uncleaved signal-anchor of sucrase-isomaltase to a cleaved signal sequence.
J. Biol. Chem.
267:16928-16933[Abstract/Free Full Text].
|
| 22.
|
Hicks, J. B., and I. Herskowitz.
1976.
Interconversion of yeast mating types. I. Direct observations of the action of the homothallism (HO) gene.
Genetics
83:245-258[Abstract/Free Full Text].
|
| 23.
|
Hostetter, M. K.
1994.
Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces.
Clin. Microbiol. Rev.
7:29-42[Abstract/Free Full Text].
|
| 24.
| Hoyer, L. L., J. E. Hecht, and M. Z. Ho. 1998. Unpublished data.
|
| 25.
|
Hoyer, L. L.,
T. L. Payne,
M. Bell,
A. M. Myers, and S. Scherer.
1998.
Candida albicans ALS3 and insights into the nature of the ALS gene family.
Curr. Genet.
33:451-459[Medline].
|
| 26.
|
Hoyer, L. L.,
S. Scherer,
A. R. Shatzman, and G. P. Livi.
1995.
Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif.
Mol. Microbiol.
15:39-54[Medline].
|
| 27.
|
Jentoft, N.
1990.
Why are proteins O-glycosylated?
Trends Biochem. Sci.
15:291-294[Medline].
|
| 28.
|
Johnston, M.,
S. Andres,
R. Brinkman,
J. Cooper,
H. Ding,
J. Dover,
Z. Du,
A. Favello,
L. Fulton,
S. Gattung,
C. Geisel,
J. Kiresten,
T. Kucaba,
L. Hiller,
M. Jier,
L. Johnston,
Y. Langston,
P. Latreille,
E. J. Louis,
C. Macri,
E. Mardis,
S. Menezes,
L. Mouser,
M. Nhan,
L. Rifkin,
L. Riles,
H. S. Peter,
E. Trevaskis,
K. Vaughan,
D. Vignati,
L. Wilcox,
P. Wohldman,
R. Waterston,
R. Wilson, and M. Vaudin.
1994.
Complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII.
Science
265:2077-2082[Abstract/Free Full Text].
|
| 29.
|
Kennedy, M. J.
1988.
Adhesion and association mechanisms of Candida albicans.
In
M. R. McGinnis (ed.), Current topics in medical mycology, vol. 2. Springer-Verlag, New York, N.Y.
|
| 30.
|
Kennedy, M. J.
1990.
Models for studying the role of fungal attachment in colonization and pathogenesis.
Mycopathologia
109:123-137[Medline].
|
| 31.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 32.
|
Larone, D. H.
1995.
Medically important fungi, 3rd ed.
American Society for Microbiology, Washington, D.C.
|
| 33.
|
Lee, K. L.,
H. R. Buckley, and C. C. Campbell.
1975.
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans.
Sabouraudia
13:148-153[Medline].
|
| 34.
| Lipke, P. N. 1998. Personal communication.
|
| 35.
|
Lipke, P. N.,
M.-H. Chen,
H. de Nobel,
J. Kurjan, and P. C. Kahn.
1995.
Homology modeling of an immunoglobulin-like domain in the Saccharomyces cerevisiae adhesion protein -agglutinin.
Protein Sci.
4:2168-2178[Medline].
|
| 36.
|
Lipke, P. N., and J. Kurjan.
1992.
Sexual agglutination in budding yeasts: structure, function, and regulation of adhesion glycoproteins.
Microbiol. Rev.
56:180-194[Abstract/Free Full Text].
|
| 37.
|
Lipke, P. N.,
D. Wojciechowicz, and J. Kurjan.
1989.
AG 1 is the structural gene for the Saccharomyces cerevisiae -agglutinin, a cell surface glycoprotein involved in cell-cell interactions during mating.
Mol. Cell. Biol.
9:3155-3165[Abstract/Free Full Text].
|
| 38.
|
Livi, G. P.,
P. Kmetz,
M. M. McHale,
L. B. Cieslinski,
G. M. Sathe,
D. P. Taylor,
R. L. Davis,
T. J. Torphy, and J. M. Balcarek.
1990.
Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.
Mol. Cell. Biol.
10:2678-2686[Abstract/Free Full Text].
|
| 39.
|
Livi, G. P.,
J. S. Lillquist,
L. M. Miles,
A. Ferrara,
G. M. Sathe,
P. L. Simon,
C. A. Meyers,
J. A. Gorman, and P. R. Young.
1991.
Secretion of N-glycosylated interleukin-1 in Saccharomyces cerevisiae using a leader peptide from Candida albicans.
J. Biol. Chem.
266:15348-15355[Abstract/Free Full Text].
|
| 40.
|
Lopez-Ribot, J. L.,
D. Gozalbo,
P. Sepulveda,
M. Casanova, and J. P. Martinez.
1995.
Preliminary characterization of the material released to the culture medium by Candida albicans yeast and mycelial cells.
Antonie Leeuwenhoek
68:195-201.
|
| 41.
|
Masuoka, J., and K. C. Hazen.
1997.
Cell wall protein mannosylation determines Candida albicans cell surface hydrophobicity.
Microbiology
143:3015-3021[Abstract/Free Full Text].
|
| 42.
|
McHale, M. M.,
L. B. Cieslinski,
W.-K. Eng,
R. K. Johnson,
T. J. Torphy, and G. P. Livi.
1991.
Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
Mol. Pharmacol.
39:109-113[Abstract].
|
| 43.
|
Odds, F. C.
1988.
Candida and candidosis, 2nd ed.
Balliere Tindall, London, England.
|
| 44.
|
Ripmaster, T. L.,
K. Shiba, and P. Schimmel.
1995.
Wide cross-species aminoacyl-tRNA synthetase replacement in vivo: yeast cytoplasmic alanine enzyme replaced by human polymyositis serum antigen.
Proc. Natl. Acad. Sci. USA
92:4932-4936[Abstract/Free Full Text].
|
| 45.
|
Rotrosen, D.,
R. A. Calderone, and J. E. Edwards.
1986.
Adherence of Candida species to host tissues and plastic surfaces.
Rev. Infect. Dis.
8:73-85[Medline].
|
| 46.
|
Santos, M. A. S., and M. F. Tuite.
1995.
The CUG codon is decoded in vivo as serine and not leucine in Candida albicans.
Nucleic Acids Res.
23:1481-1486[Abstract/Free Full Text].
|
| 47.
|
Saporito-Irwin, S. M.,
C. E. Birse,
P. S. Sypherd, and W. A. Fonzi.
1995.
PHR1, a pH-regulated gene of Candida albicans, is required for morphogenesis.
Mol. Cell. Biol.
15:601-613[Abstract].
|
| 48.
| Scherer, S. 1998. http://alces.med.umn.edu/candida.
|
| 49.
|
Shepherd, M. G.,
C. Y. Yin,
S. P. Ram, and P. A. Sullivan.
1980.
Germ tube induction in Candida albicans.
Can. J. Microbiol.
26:21-26[Medline].
|
| 50.
|
Sikorski, R. S., and P. Hieter.
1989.
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics
122:19-27[Abstract/Free Full Text].
|
| 51.
|
Staebell, M., and D. R. Soll.
1985.
Temporal and spatial differences in cell wall expansion during bud and mycelium formation in Candida albicans.
J. Gen. Microbiol.
131:1467-1480[Abstract/Free Full Text].
|
| 52.
|
Sundstrom, P.,
M. Irwin,
D. Smith, and P. S. Sypherd.
1991.
Both genes for EF-1 in Candida albicans are translated.
Mol. Microbiol.
5:1703-1706[Medline].
|
| 53.
|
Vai, M.,
I. Orlandi,
P. Cavadini,
L. Alberghina, and L. Popolo.
1996.
Candida albicans homologue of GGP1/GAS1 gene is functional in Saccharomyces cerevisiae and contains the determinants for glycosylphosphatidylinositol attachment.
Yeast
12:361-368[Medline].
|
| 54.
|
von Heijne, G.
1986.
A new method for predicting signal sequence cleavage sites.
Nucleic Acids Res.
14:4683-4690[Abstract/Free Full Text].
|
| 55.
|
White, T. C.,
L. E. Andrews,
D. Maltby, and N. Agabian.
1995.
The "universal" leucine codon CTG in the secreted aspartyl proteinase 1 (SAP1) gene of Candida albicans encodes a serine in vivo.
J. Bacteriol.
177:2953-2955[Abstract/Free Full Text].
|
| 56.
|
Wojciechowicz, D.,
C.-F. Lu,
J. Kurjan, and P. N. Lipke.
1993.
Cell surface anchorage and ligand-binding domains of the Saccharomyces cerevisiae cell adhesion protein -agglutinin, a member of the immunoglobulin superfamily.
Mol. Cell. Biol.
13:2554-2563[Abstract/Free Full Text].
|
| 57.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[Medline].
|
Journal of Bacteriology, October 1998, p. 5334-5343, Vol. 180, No. 20
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mao, Y., Zhang, Z., Gast, C., Wong, B.
(2008). C-Terminal Signals Regulate Targeting of Glycosylphosphatidylinositol-Anchored Proteins to the Cell Wall or Plasma Membrane in Candida albicans. Eukaryot Cell
7: 1906-1915
[Abstract]
[Full Text]
-
Chaffin, W. L.
(2008). Candida albicans Cell Wall Proteins. Microbiol. Mol. Biol. Rev.
72: 495-544
[Abstract]
[Full Text]
-
Brena, S., Omaetxebarria, M. J., Elguezabal, N., Cabezas, J., Moragues, M. D., Ponton, J.
(2007). Fungicidal Monoclonal Antibody C7 Binds to Candida albicans Als3. Infect. Immun.
75: 3680-3682
[Abstract]
[Full Text]
-
Dranginis, A. M., Rauceo, J. M., Coronado, J. E., Lipke, P. N.
(2007). A Biochemical Guide to Yeast Adhesins: Glycoproteins for Social and Antisocial Occasions. Microbiol. Mol. Biol. Rev.
71: 282-294
[Abstract]
[Full Text]
-
Zhao, X., Daniels, K. J., Oh, S.-H., Green, C. B., Yeater, K. M., Soll, D. R., Hoyer, L. L.
(2006). Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces.. Microbiology
152: 2287-2299
[Abstract]
[Full Text]
-
Zhao, X., Oh, S.-H., Yeater, K. M., Hoyer, L. L.
(2005). Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology
151: 1619-1630
[Abstract]
[Full Text]
-
Green, C. B., Zhao, X., Yeater, K. M., Hoyer, L. L.
(2005). Construction and real-time RT-PCR validation of Candida albicans PALS-GFP reporter strains and their use in flow cytometry analysis of ALS gene expression in budding and filamenting cells. Microbiology
151: 1051-1060
[Abstract]
[Full Text]
-
Cheng, G., Wozniak, K., Wallig, M. A., Fidel, P. L. Jr., Trupin, S. R., Hoyer, L. L.
(2005). Comparison between Candida albicans Agglutinin-Like Sequence Gene Expression Patterns in Human Clinical Specimens and Models of Vaginal Candidiasis. Infect. Immun.
73: 1656-1663
[Abstract]
[Full Text]
-
Green, C. B., Zhao, X., Hoyer, L. L.
(2005). Use of Green Fluorescent Protein and Reverse Transcription-PCR To Monitor Candida albicans Agglutinin-Like Sequence Gene Expression in a Murine Model of Disseminated Candidiasis. Infect. Immun.
73: 1852-1855
[Abstract]
[Full Text]
-
Rauceo, J. M., Gaur, N. K., Lee, K.-G., Edwards, J. E., Klotz, S. A., Lipke, P. N.
(2004). Global Cell Surface Conformational Shift Mediated by a Candida albicans Adhesin. Infect. Immun.
72: 4948-4955
[Abstract]
[Full Text]
-
de Groot, P. W. J., de Boer, A. D., Cunningham, J., Dekker, H. L., de Jong, L., Hellingwerf, K. J., de Koster, C., Klis, F. M.
(2004). Proteomic Analysis of Candida albicans Cell Walls Reveals Covalently Bound Carbohydrate-Active Enzymes and Adhesins. Eukaryot Cell
3: 955-965
[Abstract]
[Full Text]
-
Green, C. B., Cheng, G., Chandra, J., Mukherjee, P., Ghannoum, M. A., Hoyer, L. L.
(2004). RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology
150: 267-275
[Abstract]
[Full Text]
-
Zhao, X., Pujol, C., Soll, D. R., Hoyer, L. L.
(2003). Allelic variation in the contiguous loci encoding Candida albicans ALS5, ALS1 and ALS9. Microbiology
149: 2947-2960
[Abstract]
[Full Text]
-
Zhang, N., Harrex, A. L., Holland, B. R., Fenton, L. E., Cannon, R. D., Schmid, J.
(2003). Sixty Alleles of the ALS7 Open Reading Frame in Candida albicans: ALS7 Is a Hypermutable Contingency Locus. Genome Res
13: 2005-2017
[Abstract]
[Full Text]
-
Trinel, P. A., Jouault, T., Cutler, J. E., Poulain, D.
(2002). {beta}-1,2-Mannosylation of Candida albicans Mannoproteins and Glycolipids Differs with Growth Temperature and Serotype. Infect. Immun.
70: 5274-5278
[Abstract]
[Full Text]
-
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., Ghannoum, M. A.
(2001). Biofilm Formation by the Fungal Pathogen Candida albicans: Development, Architecture, and Drug Resistance. J. Bacteriol.
183: 5385-5394
[Abstract]
[Full Text]
-
Puopolo, K. M., Hollingshead, S. K., Carey, V. J., Madoff, L. C.
(2001). Tandem Repeat Deletion in the Alpha C Protein of Group B Streptococcus Is recA Independent. Infect. Immun.
69: 5037-5045
[Abstract]
[Full Text]
-
Jong, A. Y., Stins, M. F., Huang, S.-H., Chen, S. H. M., Kim, K. S.
(2001). Traversal of Candida albicans across Human Blood-Brain Barrier In Vitro. Infect. Immun.
69: 4536-4544
[Abstract]
[Full Text]
-
Hoyer, L. L., Fundyga, R., Hecht, J. E., Kapteyn, J. C., Klis, F. M., Arnold, J.
(2001). Characterization of Agglutinin-like Sequence Genes From Non-albicans Candida and Phylogenetic Analysis of the ALS Family. Genetics
157: 1555-1567
[Abstract]
[Full Text]
-
Yesland, K., Fonzi, W. A.
(2000). Allele-specific gene targeting in Candida albicans results from heterology between alleles. Microbiology
146: 2097-2104
[Abstract]
[Full Text]
-
Hoyer, L. L., Clevenger, J., Hecht, J. E., Ehrhart, E. J., Poulet, F. M.
(1999). Detection of Als Proteins on the Cell Wall of Candida albicans in Murine Tissues. Infect. Immun.
67: 4251-4255
[Abstract]
[Full Text]